类风湿关节炎临床缓解期仍持续存在表达ACPA的 switched-memory B 细胞
该横断面研究采用ELISA及多重微珠免疫分析,检测RA患者血清、滑液及B细胞培养上清中ACPA的精细特异性,发现滑液B细胞自发分泌ACPA,且治疗诱导的临床缓解对循环ACPA表达 switched-memory B 细胞负荷影响很小。
要点
- 滑液B细胞可自发分泌ACPA,外周血单核细胞组成性IgG自身抗体产生较少。
- ACPA表达 switched-memory B 细胞频率与血清IgG anti-CCP3显著相关(r=0.57,P=0.003)。
- 临床缓解对循环ACPA表达 switched-memory B 细胞负荷影响很小或没有影响。
核心结论
- RA临床缓解期仍存在表达ACPA的 switched-memory B 细胞持续存在,临床疾病活动度评分不能可靠反映病理性循环B细胞自身免疫的消退。
研究设计与样本
- 横断面研究,纳入接受甲氨蝶呤和/或肿瘤坏死因子抑制剂治疗的RA患者,检测血清、滑液及B细胞培养上清中ACPA的精细结合特异性。
主要发现
- 滑液来源培养B细胞可自发分泌ACPA,而外周血单核细胞组成性IgG自身抗体产生频率明显较低。
- 体外刺激后,外周血单核细胞分泌的IgG ACPA绝大多数来自 switched-memory B 细胞,见于所有治疗组患者。
- ACPA表达 switched-memory B 细胞频率与血清IgG anti-CCP3显著相关(r=0.57,P=0.003)。
- 治疗诱导的临床缓解对循环 switched-memory ACPA表达B细胞负荷影响很小或没有影响,部分解释体液免疫持续失调。
临床怎么用
- 临床疾病活动度评分缓解不应被视为病理性循环B细胞自身免疫已消退,停用治疗可能导致疾病复发和临床 flare。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In rheumatoid arthritis (RA), autoreactive B cells are pathogenic drivers and sources of anti-citrullinated protein antibodies (ACPAs) that are a diagnostic biomarker and predictor of worse long-term prognosis. Yet, the immunobiologic significance of persistent ACPA production at the cellular level is poorly understood. This study was undertaken to investigate the representation of ACPA-expressing switched-memory B cells in RA. METHODS: In a cross-sectional study of RA patients, we investigated the presence of continued defects in immune homeostasis as a function of disease activity. Using an enzyme-linked immunosorbent assay (ELISA) and a sensitive multiplex bead-based immunoassay, we characterized fine binding antibody specificities in sera, synovial fluid (SF), and B cell culture supernatants. In this manner, we determined the frequency and epitope reactivity patterns of ACPAs produced by SF B cells and switched-memory blood B cells and compared the latter to serum ACPA levels and disease activity scores. RESULTS: Cultured B cells from SF were shown to spontaneously secrete ACPAs, while constitutive IgG autoantibody production by peripheral blood mononuclear cells (PBMCs) was substantially less frequent. After in vitro stimulation, PBMCs secreted IgG ACPA that was overwhelmingly from switched-memory B cells, across all patient groups treated with methotrexate and/or a tumor necrosis factor inhibitor. Intriguingly, the frequencies of ACPA-expressing switched-memory B cells significantly correlated with serum IgG anti-cyclic citrullinated peptide 3 (r = 0.57, P = 0.003). Moreover, treatment-induced clinical remission had little or no effect on the circulating burden of switched-memory ACPA-expressing B cells, in part explaining the continued dysregulation of humoral immunity. CONCLUSION: Our findings rationalize why therapeutic cessation most often results in disease reactivation and clinical flare. Hence, a clinical disease activity score is not a reliable indicator of the resolution of pathologic recirculating B cell autoimmunity.
引用
- Pelzek AJ, Grönwall C, Rosenthal P, et al. Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission. Arthritis Rheumatol. 2017. PMID: 28118534. doi:10.1002/art.40053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。